Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 4 - What They Never Told You

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

MarketBeat

Earnings Preview: What to Expect From Abbott's Report

Abbott will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

Barchart

Love Dividends? 2 Passive Income Stocks to Scoop Up Now.

These consistent dividend-paying stocks could be a good addition to your portfolio.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

Barchart

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

StockNews.com

Abbott Elementary celebrates the holidays with two new episodes tonight, December 4

Abbott Elementary season 4 is winding down the year with two new holiday episodes on December 4. Here’s what you need to know about the special event.

WhatToWatch

Is Abbott Laboratories Stock Underperforming the Nasdaq?

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Why Abbott Elementary is not new tonight, November 27

Abbott Elementary is not new tonight, November 27. Here’s when fans can expect to see another new episode.

WhatToWatch

What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

Despite Abbott Laboratories’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

Barchart

‘If they don’t get care, they die’: the woman who runs the world’s largest kidney dialysis company

Helen Giza of FME is excited about the possibilities new drugs such as Ozempic could offer for renal patients

The Guardian - UK

How to ensure girls stay in STEM

Sexism in science and tech persists. We must do more to tackle it

Salon

3 Robotics Stocks Powering the Automation Revolution

Robotics is pivotal in the automation revolution, driving substantial growth in diverse sectors like air defense and healthcare. Therefore, it could be wise to consider fundamentally strong robotics stocks like RTX (RTX), Stryker (SYK), and Medtronic (MDT). Read on.

StockNews.com

Abbott's Quarterly Earnings Preview: What You Need to Know

Abbott is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.

Barchart

'Virus Hunters' Track Threats To Head Off Next Pandemic

A global network of doctors and laboratories is working to pinpoint emerging viral threats, including many driven by climate change, in a bid to head off the world's next pandemic.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

StockNews.com

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

Barchart

3 Recession-Proof Dividend Kings to Buy For a Lifetime of Income

Discover three proven, quality companies you can own to get through a looming recession.

Barchart

Is Abbott Stock Underperforming the S&P 500?

Abbott's shares have underperformed the broader S&P 500 this year, but analysts are highly bullish on the stock's potential.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Robotics Stocks to Watch for the Automation Revolution

The robotics industry’s long-term growth is fueled by rapid technological advancements and automation across several sectors. Thus, it could be wise to keep an eye on fundamentally solid robotics stocks Stryker (SYK), Honeywell International (HON), and Medtronic (MDT) to capitalize on the automation revolution. Keep reading….

StockNews.com

3 Stocks Benefiting From the AI Boom—but Not Tech Companies

Artificial intelligence (AI) has been creating ripple effects across non-tech industries with new avenues for growth and innovation. With that in mind, let’s not miss out on investing in quality stocks from different sectors: Costco Wholesale Corp. (COST), Medtronic (MDT), and Korn Ferry (KFY), which are capitalizing on the AI…

Barchart

3 Dividend Kings With Massive Dividend Growth Rates

Learn how these three dividend kings can boost your portfolio's income potential.

Barchart

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Top News

Lawsuits Filed Against Abbott Nutrition Over Infant Formula Contamination

Lawsuit filed against Abbott Nutrition over tainted infant formula linked to baby's death, raising awareness about powdered formula risks.

The Independent UK

After baby's death, Kentucky parents sue infant formula maker at center of 2022 crisis

The parents of Kentucky baby who died last fall after drinking bacteria-tainted infant formula are the latest to sue manufacturer Abbott Nutrition

The Guardian - UK

Reckitt Benckiser’s shares slump after Abbott baby formula ruling over bowel disease link

British group says claims products cause serious bowel condition NEC are ‘not supported by science’

1 … 3 4 5 6

People

Talia Shire

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.